The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - AbbVie
Stock and Other Ownership Interests - AbbVie
First-in-human study of ABBV-075 (mivebresib), a pan-inhibitor of bromodomain and extra terminal (BET) proteins, in patients (pts) with relapsed/refractory (RR) acute myeloid leukemia (AML): Preliminary data.
 
Gautam Borthakur
No Relationships to Disclose
 
Johannes E. Wolff
Employment - AbbVie
Stock and Other Ownership Interests - AbbVie
Travel, Accommodations, Expenses - AbbVie
 
Ibrahim Aldoss
Honoraria - Helocyte; Jazz Pharmaceuticals
Consulting or Advisory Role - Helocyte
Speakers' Bureau - Jazz Pharmaceuticals
Travel, Accommodations, Expenses - Helocyte; Jazz Pharmaceuticals
 
Beibei Hu
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
Travel, Accommodations, Expenses - Abbvie
 
Minh Dinh
Employment - AbbVie
Stock and Other Ownership Interests - AbbVie
 
Alison Torres
No Relationships to Disclose
 
Xiaotian Chen
Employment - AbbVie
Travel, Accommodations, Expenses - AbbVie
 
David Rizzieri
Consulting or Advisory Role - Gilead Sciences; incyte; Kite, a Gilead company; Millennium (I); novartis; onyx (I); pfizer; pharmacyclics; Sanofi; Seagen; Teva
Speakers' Bureau - Celgene; Celgene (I); Gilead Sciences; incyte; Millennium (I); Seagen
 
Anjla Sood
Employment - AbbVie
Stock and Other Ownership Interests - Abbvie; Abbvie (I)
Honoraria - QOL Medical LLC (I); Sucampo Pharmaceuticals (I)
Consulting or Advisory Role - Kimberly-Clark (I); QOL Medical LLC (I); Sucampo Pharmaceuticals (I); Takeda (I)
 
Olatoyosi Odenike
Consulting or Advisory Role - Abbvie; CTI/Baxalta; Jazz Pharmaceuticals; Pfizer
Research Funding - Abbvie (Inst); Agios (Inst); Astex Pharmaceuticals (Inst); Celgene (Inst); Gilead Sciences (Inst); Incyte (Inst); Janssen Oncology (Inst); MEI Pharma (Inst); Millennium (Inst); NS Pharma (Inst); OncoTherapy Science (Inst)
 
Brian Andrew Jonas
Consulting or Advisory Role - Celgene; Rigel
Speakers' Bureau - Celgene; Incyte; Onyx
Research Funding - Abbvie (Inst); Daiichi Sankyo (Inst); Esanex (Inst); Genentech/Roche (Inst); Glycomimetics (Inst); KaloBios (Inst); Novartis (Inst); Pharmacyclics (Inst)